Pleural Effusion Induced by Systemic Consumption of Topical Minoxidil: A Rare Case Report

Sri Hari Tanguturi Yella1, Kistigari Satyanarayana Pramod Kumar1, Sree Sudha Tanguturi Yella2

  • 1Department of Critical Care Medicine, KIMS Hospital, Telangana, India.

Current Drug Safety
|June 9, 2022
PubMed
Abstract

Insights

Topical minoxidil, when taken orally, can cause pleural effusion even in individuals without chronic kidney disease. This rare adverse drug reaction highlights the importance of considering minoxidil as a potential cause of pleural effusion.

Area of Science:

  • Pulmonology
  • Pharmacology
  • Internal Medicine

Background:

  • Pleural effusions are commonly associated with conditions like cancer, infections, and connective tissue diseases.
  • Adverse drug reactions are an occasional cause of pleural effusions.
  • Systemic minoxidil use is a known cause of pleural effusions, particularly in patients with chronic kidney disease.

Observation:

  • A case is presented of a patient without chronic kidney disease who developed pleural effusion.
  • The effusion resulted from unintentional oral ingestion of topical minoxidil.
  • Clinical presentation included hypoxia, dullness to percussion, asymmetrical chest expansion, diminished air entry, and bilateral opacities on chest x-ray.

Findings:

  • Chest x-ray revealed bilateral pleural opacities.
  • Chest ultrasonography confirmed minimal pleural effusions.
  • The patient's condition resolved completely with diuretic and airway management.

Implications:

  • Topical minoxidil is widely used for hair loss, often without medical supervision.
  • Physicians and pulmonologists should be aware of rare side effects of topical minoxidil.
  • Pleural effusion should be considered a potential differential diagnosis in cases of minoxidil exposure.

Related Concept Videos

Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
277
Pleural Effusion I: Introduction01:25

Pleural Effusion I: Introduction

Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
2.0K
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
390
Pneumothorax-I01:26

Pneumothorax-I

A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
379